FY2023 NIH awards · Principal investigators
Urology at Icahn School of Medicine at Mount Sinai
New York, NY
Funding
$3.4M
$3,435,990
Awards
7
FY2023 NIH awards in Urology
Principal investigators
7
7 lead a grant here, 0 co-investigators
- NIH names only the principal investigators on an award, so this page lists only them. The department is the award's: it is where ScienceDex counts the award, not a list of the department's members.
- These are the awards in the Urology row of the Icahn School of Medicine at Mount Sinai page.
Leads a grant in this department
7 contact PIs of these awards, by the funding they lead. Other principal investigators on an award are listed with it and under Co-investigators.
Chakraborty, Goutam
Leads 1 award · $729,450
- 1R01CA274967-01A1Department: NIH department codeFunctional Characterization and Development of Therapeutic Paradigms for DNA Damage Repair (DDR)-deficient Lethal Prostate Cancer$729,450award amount
Bhardwaj, Nina
Leads 1 award · $689,332
- 5R01CA249175-04Department: NIH department codeDissecting myeloid cell-mediated resistance to immune checkpoint blockade in bladder cancer$689,332award amount
Horowitz, Amir
Leads 1 award · $686,087
- 1R01CA269954-01A1Department: NIH department codeHLA-E and NKG2A define a novel immune checkpoint axis in non-muscle-invasive bladder cancer$686,087award amount
Padanilam, Babu Joseph
Leads 1 award · $454,321
- 5R01DK120846-04Department: NIH department codeNeuromodulation of long-term sequelae of ischemic acute kidney injury$454,321award amount
Kyprianou, Natasha
Leads 1 award · $447,321
- 5R01CA232574-06Department: NIH department codeTreatment-Induced Phenotypic Reprogramming in Prostate Cancer$447,321award amount
Horowitz, Amir
Leads 1 award · $237,023
- 1R21CA274148-01A1Department: NIH department codeIdentifying novel resistance mechanisms in non-muscle invasive bladder cancer treated with Bacillus Calmette-Guerin (BCG)$237,023award amount
Arriaga, Juan Martin
Leads 1 award · $192,456
- 5K22CA258806-02Department: NIH department codeIdentification of therapeutic vulnerabilities in prostate cancer bone metastasis$192,456award amount